RESOLVE-AF: Clinical Evaluation of the Ablacath™ Mapping Catheter and Ablamap® System Utilizing Electrographic Flow (EGF) Mapping to Resolve Extra-PV Sources of Atrial Fibrillation and Guide Ablation Therapy.

Clinical trial NCT05883631 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05883631
Sponsor: Cortex
Status: ACTIVE_NOT_RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Atrial Fibrillation Atrial Fibrillation, Persistent Atrial Fibrillation Paroxysmal Arrhythmia Arrhythmias, Cardiac Atrial Flutter Atrial Fibrillation, Paroxysmal or Persistent Atrial Arrhythmia Atrial Tachycardia

Start date: 2023-10-23
Primary completion: 2026-01-01
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.